Frontiers in Pharmacology (Sep 2019)

Systematically Analyzing the Pathogenic Variations for Acute Intermittent Porphyria

  • Yibao Fu,
  • Jinmeng Jia,
  • Lishu Yue,
  • Ruiying Yang,
  • Yongli Guo,
  • Yongli Guo,
  • Yongli Guo,
  • Xin Ni,
  • Xin Ni,
  • Xin Ni,
  • Tieliu Shi,
  • Tieliu Shi

DOI
https://doi.org/10.3389/fphar.2019.01018
Journal volume & issue
Vol. 10

Abstract

Read online

The rare autosomal dominant disorder acute intermittent porphyria (AIP) is caused by the deficient activity of hydroxymethylbilane synthase (HMBS). The symptoms of AIP are acute neurovisceral attacks which are induced by the dysfunction of heme biosynthesis. To better interpret the underlying mechanism of clinical phenotypes, we collected 117 HMBS gene mutations from reported individuals with AIP and evaluated the mutations’ impacts on the corresponding protein structure and function. We found that several mutations with most severe clinical symptoms are located at dipyromethane cofactor (DPM) binding domain of HMBS. Mutations on these residues likely significantly influence the catalytic reaction. To infer new pathogenic mutations, we evaluated the pathogenicity for all the possible missense mutations of HMBS gene with different bioinformatic prediction algorithms, and identified 34 mutations with serious pathogenicity and low allele frequency. In addition, we found that gene PPARA may also play an important role in the mechanisms of AIP attacks. Our analysis about the distribution frequencies of the 23 variations revealed different distribution patterns among eight ethnic populations, which could help to explain the genetic basis that may contribute to population disparities in AIP prevalence. Our systematic analysis provides a better understanding for this disease and helps for the diagnosis and treatment of AIP.

Keywords